• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BC R 1X40 US; BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BC R 1X40 US; BONE CEMENT Back to Search Results
Catalog Number 110034355
Medical Device Problem Code Loosening of Implant Not Related to Bone-Ingrowth (4002)
Health Effect - Clinical Codes Failure of Implant (1924); Pain (1994)
Date of Event 05/23/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D10: item name: articulation kit size 4 1 axle pin, 1 humeral bearing a, 2 ulnar bearings b sterile product do not resterilize; item number: 00840009400; lot: 64295459.Item name: ulnar component plasma sprayed size 4 75 mm length right for cemented use only; item number: 00840002407; lot: 64264471.Item name: humeral screw kit 2 humeral screws; item number: 00840009000; lot: 64302321.Item name: humeral component plasma sprayed size 4 100 mm length for cemented use only; item number: 00840004410; lot: 64290038.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted. .
 
Event or Problem Description
It was reported a patient had a right total elbow arthroplasty.Subsequently developed significant pain and underwent a revision due to loosening.The cemented humeral component remained implanted, while the cemented ulna, humeral screws, and articulation kit were all revised without complications.Approximately 3 years and 5 months post-implantation.Attempts have been made and all additional information received has been included in this report.
 
Additional Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional and/or corrected information.No product was returned or pictures provided; visual and dimensional evaluations could not be performed.A review of the device manufacturing records confirmed no abnormalities or deviations.Review of the complaint history identified additional similar complaints for the reported item and the part and lot combination.Medical records were provided and reviewed by a health care professional.Review of the available records identified the following: mechanical failure of ulnar component in a previously revised elbow, history of muscle flap overlying elbow, significant pain, ¿65 year old female with cement allergy¿.General anesthesia.Surgical incision in posterior aspect utilized.Muscle flap in place overlying direct approach, therefore, came around medially to elevate the muscle flap without damaging the vascular pedicle.Ulnar component grossly loose.Absence of the olecranon.3rd generation cement technique used.Muscle flap closed in a layered fashion, no intra-op complications/events.A definitive root cause cannot be determined.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
No further event information available at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BC R 1X40 US
Common Device Name
BONE CEMENT
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key21419667
Report Number3006946279-2025-00019
Device Sequence Number12759174
Product Code MBB
UDI-Device Identifier00880304990197
UDI-Public(01)00880304990197(17)210731(10)835AAE2507
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K150850
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date07/31/2021
Device Catalogue Number110034355
Device Lot Number835AAE2507
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/31/2025
Supplement Date Received by Manufacturer05/20/2025
Initial Report FDA Received Date02/20/2025
Supplement Report FDA Received Date05/20/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/07/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10 NARRATIVE.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexFemale
-
-